- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03030963
Effect of Equal Ratio Ventilation on Blood Loss During Posterior Lumbar Interbody Fusion Surgery
August 3, 2018 updated by: Ji-young Kim, Gangnam Severance Hospital
Effect of Equal Ratio Ventilation on Blood Loss During Posterior Lumbar Interbody Fusion Surgery: A Randomized Controlled Trial
Ventilator mode change was associated with decrease in blood loss during posterior lumbar interbody fusion (PLIF) due to decrease in the peak inspiratory pressure (PIP).
The purpose of this study was to determine the effect of equal ratio ventilation (ERV), which sets the I:E ratio of the ventilator to 1:1 during volume controlled ventilaiton, on surgical blood loss during PLIF.
Investigators hypothesized that ERV would decrease surgical blood loss due to decrease in the PIP.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
After anesthesia, patients will receive ventilator settings according to theri group.
The CVP will be measured before and after the prone position to ensure the proper positioning.
Airway pressures including peak inspiratory pressure, mean/plateau airway pressure, arterial blood gas analysis data, hct, lactate, body temperature, mean arterial pressure, cardiac index.
Recodings will be done 5min afte the induction, 5 min after the prone positioning, sikin suture, and 5min after supine position.
Amount of bleeding, coagulation profile and Hct will be recorded 72 hrs after the surgery.
Study Type
Interventional
Enrollment (Actual)
36
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 06273
- Gangnam Severance Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 1) Age : 20~75 yr-old 2) Surgery : Posterior lumbar interbody fusion(PLIF) 2~3 levels
Exclusion Criteria:
- 1) Urgent or Emergency case 2) Previous lnstrumentation of lumbar spine (Exclusion : Discectomy, Partial hemilaminiectomy, etc) 3) Concurrent other operation 4) Patients who cannot understand informed consent (ex. Illiterate, Foreigner) 5) Obesity (BIM>30kg/m2) 6) Recent myocardial infarction (within 3 months) 7) Reduced left and right ventricular function (Ejection fraction<40%) or Congestive heart failure 8) Preoperative dysrhythmia 9) Aspirin or Plavix during perioperative periods 10) Lung disease 11) Chronic kidney disease or Dialysis 12) Severe hepatic disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Equal-ratio ventilation(ERV) group
ventilator inspiration to expiration ratio will be set 1:1.
|
Set the inspiratory to expiratory ratio 1:1 during mechanical ventilation
Other Names:
|
|
Active Comparator: Control group
ventilator inspiration to expiration ratio will be set 1:2.
|
Set the inspiratory to expiratory ratio 1:2 during mechanical ventilation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The amount of intraoperative surgical bleeding
Time Frame: At the end of the surgery, approximately 4 hrs.
|
The surgical blood loss was compared in the two groups (ERV vs. conrol) during posterior lumbar interbody fusion(PLIF) in prone position.
|
At the end of the surgery, approximately 4 hrs.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jiyoung Kim, Gangnam Severance Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 6, 2017
Primary Completion (Actual)
March 4, 2018
Study Completion (Actual)
March 31, 2018
Study Registration Dates
First Submitted
January 22, 2017
First Submitted That Met QC Criteria
January 24, 2017
First Posted (Estimate)
January 25, 2017
Study Record Updates
Last Update Posted (Actual)
August 6, 2018
Last Update Submitted That Met QC Criteria
August 3, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 3-2016-0241
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Loss, Surgical
-
The University of Texas Health Science Center at...CompletedMyomectomy; Surgical Blood LossUnited States
-
Assiut UniversityCompletedHepatectomy, Surgical Blood Loss, TerlipressinEgypt
-
i-SEPCompletedHemorrhage | Blood Loss | Surgical Blood LossFrance
-
Northwell HealthCompletedSurgical Blood LossUnited States
-
University Health Network, TorontoThe Physicians' Services Incorporated FoundationCompletedTotal Knee Arthroplasty | Surgical Blood LossCanada
-
CSL BehringCompletedSurgical Blood Loss | Postoperative Blood LossUnited Kingdom, Canada, Japan, Italy, Poland, Germany, Czech Republic, Austria, Brazil, Denmark, Finland
-
Cubist Pharmaceuticals LLCCompletedSurgical Procedures, Operative | BloodlossUnited States, Canada
-
Population Health Research InstituteCompletedBleeding | Surgical Blood LossCanada
-
Cubist Pharmaceuticals LLCCompletedSurgical Procedures, Operative | BloodlossGermany, Poland, United States
-
Haermonics BVAvaniaNot yet recruitingSurgical Blood Loss | Surgical Complication
Clinical Trials on Equal ratio ventilation(ERV)
-
Illinois Institute of TechnologyElevateCompletedAsthma | Pollution; ExposureUnited States
-
Ain Shams UniversityCompletedTracheo Esophageal FistulaEgypt
-
Gachon University Gil Medical CenterCompleted
-
Kasr El Aini HospitalNot yet recruitingHypotension | Induction of AnesthesiaEgypt
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedLung Diseases | Pulmonary Embolism
-
King's College LondonKing's College Hospital NHS TrustCompletedBronchopulmonary DysplasiaUnited Kingdom
-
Başakşehir Çam & Sakura City HospitalCompletedAcute Respiratory Distress Syndrome (ARDS) | Ventilated Patient in Intensive CareTurkey
-
All India Institute of Medical Sciences, RishikeshUnknownLung Injury, Acute
-
Erasmus Medical CenterRecruitingMechanical Ventilation | Acute Hypoxemic Respiratory FailureNetherlands
-
Zheng QingjiangNot yet recruiting